Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...
Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...
Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...
The Punch Newspapers on MSN1h
Experts decry diabetes drugs cost as patients reach 14mMedical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...
Dr. Meijing Wu is described by friends and colleagues as a distinguished biostatistician and “a kind and generous friend who ...
2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...
For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...
Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...
MINNEAPOLIS, MN, US, Nov. 14, 2024 (GLOBE NEWSWIRE) -- (OTCQB: PETV, PETVW), a leading biomedical company delivering ...
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, marked the sixth anniversary since its ...
Baidu CEO’s life sciences startup sees artificial intelligence as the inevitable force driving transformation in drug ...
Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback